Geneva Partners
ABBV icon

Geneva Partners’s AbbVie ABBV Stock Holding History

Geneva Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.12M Buy
+11,942
New +$3.06M 0.93% 35

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Geneva Partners's ABBV Position: Q3 2026 in Review

Geneva Partners opened a new position in AbbVie (ABBV) in Q3 2026: 11,942 shares worth $3.12M. The stake represents 0.93% of the portfolio and ranks #35 among its holdings.

2,685 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Geneva Partners held 11,942 shares of AbbVie worth $3.12M as of Q3 2026.
  • AbbVie was a new Geneva Partners position in Q3 2026.
  • AbbVie made up 0.93% of Geneva Partners's portfolio in Q3 2026, its #35 holding.
  • 2,685 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Geneva Partners's 13F filing for Q3 2026, filed 26 Oct 2026.